首页 > 专栏 > The Lancet The Lancet 共 217 条资讯 [Articles] Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial 2026-06-28 11:43:09 [Department of Error] Department of Error 2026-06-28 11:43:09 [Correspondence] China–Nepal border catastrophic floods: a planetary health alarm 2026-06-28 11:43:09 [Correspondence] Thirlwall, Bier's spots, and the Letby murders 2026-06-28 11:43:09 [Correspondence] Health care criminalised in Italian immigration detention centres 2026-06-28 11:43:09 [Perspectives] Richard Dadd's beguiling art 2026-06-28 11:43:09 [Comment] Tailoring levels of evidence in trials comparing common treatments 2026-06-28 11:43:09 [Comment] Hepatitis C—is discrimination preventing elimination? 2026-06-28 11:43:09 [Correspondence] Prioritising the future of youth is an urgent political choice 2026-06-28 11:43:09 [Perspectives] John Wong: making an impact on population health at scale 2026-06-28 11:43:09 [Comment] 21st century global threats to health are not what you think 2026-06-28 11:43:09 [The Lancet Commissions] The Lancet Commission on 21st century global threats to health 2026-06-28 11:43:09 [Review] Addressing threats to future global health—what is the right timeframe? 2026-06-28 11:43:09 [Editorial] Rethinking threats to human survival 2026-06-28 11:43:09 [Health Policy] Strengthening health systems to prioritise, provide care, and prevent osteoarthritis: a roadmap for global health policy 2026-06-28 11:43:09 [Comment] Deucrictibant: a novel oral on-demand treatment for hereditary angioedema 2026-06-28 11:43:09 [Comment] Conversational diagnostic AI in primary care: what happens after it speaks? 2026-06-28 11:43:09 [Articles] Conversational diagnostic artificial intelligence in ambulatory primary care: a prospective feasibility study 2026-06-28 11:43:09 [Correspondence] Bundibugyo virus: coordinating a cross-border response 2026-06-28 11:43:09 [Articles] Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial 2026-06-28 11:43:09 « 上一页1234…11下一页 » 相关分类 The Lancet ScienceDirect Publication: The Lancet ScienceDirect Publication: The Lancet Oncology The Lancet Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet Digital Health The Lancet Gastroenterology & Hepatology The Lancet Global Health The Lancet HIV The Lancet Haematology The Lancet Healthy Longevity The Lancet Infectious Diseases The Lancet Microbe The Lancet Neurology The Lancet Oncology The Lancet Planetary Health The Lancet Psychiatry